KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 142 filers reported holding KURA ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $476,028 | -20.6% | 52,196 | -7.8% | 0.06% | -21.8% |
| Q2 2023 | $599,198 | -13.5% | 56,635 | -0.0% | 0.08% | -17.9% |
| Q1 2023 | $692,817 | -1.4% | 56,649 | +0.0% | 0.10% | -7.8% |
| Q4 2022 | $702,840 | -9.2% | 56,635 | 0.0% | 0.10% | -28.0% |
| Q3 2022 | $774,000 | -25.5% | 56,635 | -0.2% | 0.14% | -45.2% |
| Q2 2022 | $1,039,000 | -98.2% | 56,724 | -93.8% | 0.26% | -66.7% |
| Q1 2022 | $56,635,000 | +7023.9% | 910,690 | +1503.0% | 0.78% | +253.2% |
| Q4 2021 | $795,000 | -25.0% | 56,813 | +0.3% | 0.22% | -25.8% |
| Q3 2021 | $1,060,000 | -10.2% | 56,635 | -0.0% | 0.30% | -23.1% |
| Q2 2021 | $1,181,000 | -19.3% | 56,656 | +9.4% | 0.39% | -27.6% |
| Q1 2021 | $1,464,000 | -19.7% | 51,792 | -7.3% | 0.54% | -19.6% |
| Q4 2020 | $1,824,000 | – | 55,869 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
| GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
| Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
| BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
| Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
| Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
| NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
| DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
| PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |